Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection
about
Drug-induced reactivation of apoptosis abrogates HIV-1 infectionModulation of cytokine release and gene expression by the immunosuppressive domain of gp41 of HIV-1Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infectionImmunovirological parameters and cytokines in HIV infectionInduction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus InfectionsFunctional contributions of carbohydrate on AIDS virus glycoproteinHIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infectionMechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic ControllersInnate immune activation in primary HIV-1 infection.HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression.Tumor necrosis factor α is associated with viral control and early disease progression in patients with HIV type 1 infection.Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection.Lack of evidence for mtDNA as a biomarker of innate immune activation in HIV infectionLack of interleukin-10-mediated anti-inflammatory signals and upregulated interferon gamma production are linked to increased intestinal epithelial cell apoptosis in pathogenic simian immunodeficiency virus infectionCD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis.Epigenetic control of IRF1 responses in HIV-exposed seronegative versus HIV-susceptible individuals.T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trialImmunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.Effect of MHC haplotype on immune response upon experimental SHIVSF162P4cy infection of Mauritian cynomolgus macaquesMultisite comparison of high-sensitivity multiplex cytokine assays.Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infectionA non-specific biomarker of disease activity in HIV/AIDS patients from resource-limited environments.The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.Rapid and Slow Progressors Show Increased IL-6 and IL-10 Levels in the Pre-AIDS Stage of HIV Infection.Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine developmentMetabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.Induction of endogenous retroelements as a potential mechanism for mouse-specific drug-induced carcinogenicity.Elevated cytokine and chemokine levels in the placenta are associated with in-utero HIV-1 mother-to-child transmissionDual role of autophagy in HIV-1 replication and pathogenesisCross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults.Association of serum cytokines with oral HPV clearance.Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.Acute human immunodeficiency virus syndrome presenting with hemophagocytic lymphohistiocytosis.Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV/AIDS disease.Innate immune responses in primary HIV-1 infection.Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation.IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells.
P2860
Q21090718-223FF09D-868F-43B1-90EF-7AFCB4A994D0Q21133706-2E2E86F1-11BE-46C0-B013-F67C4FF2D5C0Q24564396-BB845726-D541-4574-908B-FEA1E4D67424Q26829264-36FC8A7A-05D3-4399-AADE-08816DDBE040Q27488278-0411C6B2-DE95-4CDD-A0B8-141259ADC18FQ30397572-8F53BA3F-8379-4E3C-97C6-A3706B8E8593Q33305012-51CBDE70-B02B-442A-BF60-61700D4E91BAQ33576664-803D3306-F940-4977-AA30-A5B2F2C3F7A1Q33828507-A3926AFC-D226-488D-A155-1141A32D547CQ34155538-3E22F591-E928-4D86-9723-A45C592C88C8Q34275430-5A913D92-E309-4F4E-AAEC-C1CCEB2FA516Q34402041-9056F7B2-BE60-44BD-83D8-3A5A355EE827Q34430248-C6F14C18-B916-4DD9-9146-3B21A4E509CEQ34441167-4584ED31-0B99-4203-A2A2-316A51BBC8A5Q34500351-09F50F75-BABD-4E35-90E3-DCC9DDA5403DQ34594582-79BA16CD-05CE-4E23-8B9B-3C553C643C89Q34633003-D9D286D0-F426-4BCA-936C-6A5518B0CC95Q34707439-D860524B-2C31-46D0-A624-155D66B1B5D7Q34764361-813FCBBA-35FA-44D2-AB4F-B1339A306063Q35006056-3E5B7795-9ED8-43FF-A250-5FC391D9B5D6Q35061216-5255259D-B1A2-4BD1-BCA9-5DD98A738686Q35138516-0C8E913A-67C6-46D9-8AA6-B32F760F482FQ35138815-A156EAC6-F295-48B0-BC0B-58B566597111Q35617066-80B48B8F-0F09-4104-89D3-CF21757C1C1CQ35780654-B9F20800-1263-488B-8BE1-0E5CB2E79562Q35857580-DCEF3916-E242-45E0-8902-3C43B736F28FQ36026644-EB0D4264-BF42-4271-9302-0E4D08331587Q36162133-2F854BCC-CB15-44B5-9667-C6877C887B86Q36250357-ACE41579-E8EC-44B1-86C3-1CEDEA5A5B10Q36363198-CD8557E2-9570-4974-AA9E-25F128ACF41EQ36421344-966059F1-7BA0-4990-92AD-61372427826FQ36445102-4DE10ABC-0C75-4278-8A9B-4B5DCC273D1AQ36736469-BB13D72B-CAF4-40AC-A9C4-A0D1ED98E4D5Q36923830-94342EB6-1822-4FA6-90EA-B484416DA2D7Q37039032-C5FD7424-8E29-4BD3-A3C4-9A226C4CBF57Q37040999-A0FA0BE9-462A-4B9F-A6CC-1EF40E629A4FQ37194615-0EB5C2C1-90B9-4F1A-8DD9-33DDD68BABDDQ37227226-9908848C-2F6F-494F-BB56-CE6089D92E4BQ37262786-017E8122-747C-47A8-B143-4ACFD15A99F0Q37271034-2059E3DE-A078-4A7C-A5DE-7490A98F3D42
P2860
Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection
@ast
Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection
@en
Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection
@nl
type
label
Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection
@ast
Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection
@en
Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection
@nl
prefLabel
Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection
@ast
Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection
@en
Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection
@nl
P2093
P2860
P3181
P356
P1476
Elevations in IL-10, TNF-alpha ...... point of HIV Type 1 infection
@en
P2093
Brandee L Pappalardo
Brian Custer
Gerald Spotts
Philip J Norris
P2860
P304
P3181
P356
10.1089/AID.2006.22.757
P577
2006-08-01T00:00:00Z